Serveur d'exploration sur le thulium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In vivo sodium chemical shift imaging.

Identifieur interne : 000777 ( PubMed/Checkpoint ); précédent : 000776; suivant : 000778

In vivo sodium chemical shift imaging.

Auteurs : S J Kohler [États-Unis] ; N H Kolodny ; A C Celi ; T A Burr ; D. Weinberg ; D J D'Amico ; E S Gragoudas

Source :

RBID : pubmed:1310341

Descripteurs français

English descriptors

Abstract

The shift reagents thulium(III) 1,4,7,10-tetraazacyclododecane N,N',N",N"'tetramethylenephosphonate (TmDOTP5-), and dysprosium(III)triethylenetetramine-hexaacetate (DyTTHA3-) are compared in this work for their uses in sodium chemical shift imaging (NaCSI). In a series of experiments using phantoms we evaluated the relative contributions of bulk magnetic susceptibility (BMS) effects and hyperfine shifts to the induced 23Na chemical shift for these two shift reagents. The ratios of BMS effects to hyperfine shifts suggest that TmDOTP5- should be a more effective shift reagent than DyTTHA3- for 23Na NMR spectroscopy as well as NaCSI. The dependence on pH and free Ca2+ concentration of the 23Na NMR frequency shift induced by TmDOTP5- was evaluated. It was found that TmDOTP5- produces good spectral resolution under physiologic conditions. Examples presented from in vivo NaCSI experiments using TmDOTP5- to study diffusion in the posterior chamber of the rabbit eye and to monitor the rate of clearance of aqueous fluid from the anterior chamber demonstrate the effectiveness of this new shift reagent and of the NaCSI technique for in vivo studies.

PubMed: 1310341


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:1310341

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">In vivo sodium chemical shift imaging.</title>
<author>
<name sortKey="Kohler, S J" sort="Kohler, S J" uniqKey="Kohler S" first="S J" last="Kohler">S J Kohler</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Medicine, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kolodny, N H" sort="Kolodny, N H" uniqKey="Kolodny N" first="N H" last="Kolodny">N H Kolodny</name>
</author>
<author>
<name sortKey="Celi, A C" sort="Celi, A C" uniqKey="Celi A" first="A C" last="Celi">A C Celi</name>
</author>
<author>
<name sortKey="Burr, T A" sort="Burr, T A" uniqKey="Burr T" first="T A" last="Burr">T A Burr</name>
</author>
<author>
<name sortKey="Weinberg, D" sort="Weinberg, D" uniqKey="Weinberg D" first="D" last="Weinberg">D. Weinberg</name>
</author>
<author>
<name sortKey="D Amico, D J" sort="D Amico, D J" uniqKey="D Amico D" first="D J" last="D'Amico">D J D'Amico</name>
</author>
<author>
<name sortKey="Gragoudas, E S" sort="Gragoudas, E S" uniqKey="Gragoudas E" first="E S" last="Gragoudas">E S Gragoudas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1992">1992</date>
<idno type="RBID">pubmed:1310341</idno>
<idno type="pmid">1310341</idno>
<idno type="wicri:Area/PubMed/Corpus">000803</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000803</idno>
<idno type="wicri:Area/PubMed/Curation">000803</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000803</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000803</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000803</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">In vivo sodium chemical shift imaging.</title>
<author>
<name sortKey="Kohler, S J" sort="Kohler, S J" uniqKey="Kohler S" first="S J" last="Kohler">S J Kohler</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Medicine, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kolodny, N H" sort="Kolodny, N H" uniqKey="Kolodny N" first="N H" last="Kolodny">N H Kolodny</name>
</author>
<author>
<name sortKey="Celi, A C" sort="Celi, A C" uniqKey="Celi A" first="A C" last="Celi">A C Celi</name>
</author>
<author>
<name sortKey="Burr, T A" sort="Burr, T A" uniqKey="Burr T" first="T A" last="Burr">T A Burr</name>
</author>
<author>
<name sortKey="Weinberg, D" sort="Weinberg, D" uniqKey="Weinberg D" first="D" last="Weinberg">D. Weinberg</name>
</author>
<author>
<name sortKey="D Amico, D J" sort="D Amico, D J" uniqKey="D Amico D" first="D J" last="D'Amico">D J D'Amico</name>
</author>
<author>
<name sortKey="Gragoudas, E S" sort="Gragoudas, E S" uniqKey="Gragoudas E" first="E S" last="Gragoudas">E S Gragoudas</name>
</author>
</analytic>
<series>
<title level="j">Magnetic resonance in medicine</title>
<idno type="ISSN">0740-3194</idno>
<imprint>
<date when="1992" type="published">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Anterior Chamber (metabolism)</term>
<term>Calcium (chemistry)</term>
<term>Chelating Agents</term>
<term>Diffusion</term>
<term>Dysprosium</term>
<term>Edetic Acid (analogs & derivatives)</term>
<term>Electron Spin Resonance Spectroscopy</term>
<term>Hydrogen-Ion Concentration</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Models, Structural</term>
<term>Organometallic Compounds</term>
<term>Organophosphorus Compounds</term>
<term>Rabbits</term>
<term>Sodium (chemistry)</term>
<term>Sodium (pharmacokinetics)</term>
<term>Vitreous Body (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide édétique (analogues et dérivés)</term>
<term>Animaux</term>
<term>Calcium ()</term>
<term>Chambre antérieure du bulbe oculaire (métabolisme)</term>
<term>Chélateurs</term>
<term>Composés organiques du phosphore</term>
<term>Composés organométalliques</term>
<term>Concentration en ions d'hydrogène</term>
<term>Corps vitré (métabolisme)</term>
<term>Diffusion</term>
<term>Dysprosium</term>
<term>Lapins</term>
<term>Maquettes de structure</term>
<term>Sodium ()</term>
<term>Sodium (pharmacocinétique)</term>
<term>Spectroscopie de résonance de spin électronique</term>
<term>Spectroscopie par résonance magnétique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Edetic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Calcium</term>
<term>Sodium</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Acide édétique</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Anterior Chamber</term>
<term>Vitreous Body</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Chambre antérieure du bulbe oculaire</term>
<term>Corps vitré</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr">
<term>Sodium</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Sodium</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chelating Agents</term>
<term>Diffusion</term>
<term>Dysprosium</term>
<term>Electron Spin Resonance Spectroscopy</term>
<term>Hydrogen-Ion Concentration</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Models, Structural</term>
<term>Organometallic Compounds</term>
<term>Organophosphorus Compounds</term>
<term>Rabbits</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Calcium</term>
<term>Chélateurs</term>
<term>Composés organiques du phosphore</term>
<term>Composés organométalliques</term>
<term>Concentration en ions d'hydrogène</term>
<term>Diffusion</term>
<term>Dysprosium</term>
<term>Lapins</term>
<term>Maquettes de structure</term>
<term>Sodium</term>
<term>Spectroscopie de résonance de spin électronique</term>
<term>Spectroscopie par résonance magnétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The shift reagents thulium(III) 1,4,7,10-tetraazacyclododecane N,N',N",N"'tetramethylenephosphonate (TmDOTP5-), and dysprosium(III)triethylenetetramine-hexaacetate (DyTTHA3-) are compared in this work for their uses in sodium chemical shift imaging (NaCSI). In a series of experiments using phantoms we evaluated the relative contributions of bulk magnetic susceptibility (BMS) effects and hyperfine shifts to the induced 23Na chemical shift for these two shift reagents. The ratios of BMS effects to hyperfine shifts suggest that TmDOTP5- should be a more effective shift reagent than DyTTHA3- for 23Na NMR spectroscopy as well as NaCSI. The dependence on pH and free Ca2+ concentration of the 23Na NMR frequency shift induced by TmDOTP5- was evaluated. It was found that TmDOTP5- produces good spectral resolution under physiologic conditions. Examples presented from in vivo NaCSI experiments using TmDOTP5- to study diffusion in the posterior chamber of the rabbit eye and to monitor the rate of clearance of aqueous fluid from the anterior chamber demonstrate the effectiveness of this new shift reagent and of the NaCSI technique for in vivo studies.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">1310341</PMID>
<DateCreated>
<Year>1992</Year>
<Month>03</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>1992</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0740-3194</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>23</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1992</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Magnetic resonance in medicine</Title>
<ISOAbbreviation>Magn Reson Med</ISOAbbreviation>
</Journal>
<ArticleTitle>In vivo sodium chemical shift imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>77-88</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The shift reagents thulium(III) 1,4,7,10-tetraazacyclododecane N,N',N",N"'tetramethylenephosphonate (TmDOTP5-), and dysprosium(III)triethylenetetramine-hexaacetate (DyTTHA3-) are compared in this work for their uses in sodium chemical shift imaging (NaCSI). In a series of experiments using phantoms we evaluated the relative contributions of bulk magnetic susceptibility (BMS) effects and hyperfine shifts to the induced 23Na chemical shift for these two shift reagents. The ratios of BMS effects to hyperfine shifts suggest that TmDOTP5- should be a more effective shift reagent than DyTTHA3- for 23Na NMR spectroscopy as well as NaCSI. The dependence on pH and free Ca2+ concentration of the 23Na NMR frequency shift induced by TmDOTP5- was evaluated. It was found that TmDOTP5- produces good spectral resolution under physiologic conditions. Examples presented from in vivo NaCSI experiments using TmDOTP5- to study diffusion in the posterior chamber of the rabbit eye and to monitor the rate of clearance of aqueous fluid from the anterior chamber demonstrate the effectiveness of this new shift reagent and of the NaCSI technique for in vivo studies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kohler</LastName>
<ForeName>S J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kolodny</LastName>
<ForeName>N H</ForeName>
<Initials>NH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Celi</LastName>
<ForeName>A C</ForeName>
<Initials>AC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Burr</LastName>
<ForeName>T A</ForeName>
<Initials>TA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weinberg</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>D'Amico</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gragoudas</LastName>
<ForeName>E S</ForeName>
<Initials>ES</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>RR00995</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Magn Reson Med</MedlineTA>
<NlmUniqueID>8505245</NlmUniqueID>
<ISSNLinking>0740-3194</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002614">Chelating Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009943">Organophosphorus Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C069929">thulium(III) 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetramethylenephosphonate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1D4N45714Q</RegistryNumber>
<NameOfSubstance UI="D004419">Dysprosium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>869-52-3</RegistryNumber>
<NameOfSubstance UI="C026059">triethylenetetraminehexaacetic acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9G34HU7RV0</RegistryNumber>
<NameOfSubstance UI="D004492">Edetic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9NEZ333N27</RegistryNumber>
<NameOfSubstance UI="D012964">Sodium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>SY7Q814VUP</RegistryNumber>
<NameOfSubstance UI="D002118">Calcium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000867">Anterior Chamber</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002118">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002614">Chelating Agents</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004058">Diffusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004419">Dysprosium</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004492">Edetic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004578">Electron Spin Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006863">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008961">Models, Structural</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009942">Organometallic Compounds</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009943">Organophosphorus Compounds</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011817">Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012964">Sodium</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000493">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014822">Vitreous Body</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1992</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1992</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1992</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1310341</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Burr, T A" sort="Burr, T A" uniqKey="Burr T" first="T A" last="Burr">T A Burr</name>
<name sortKey="Celi, A C" sort="Celi, A C" uniqKey="Celi A" first="A C" last="Celi">A C Celi</name>
<name sortKey="D Amico, D J" sort="D Amico, D J" uniqKey="D Amico D" first="D J" last="D'Amico">D J D'Amico</name>
<name sortKey="Gragoudas, E S" sort="Gragoudas, E S" uniqKey="Gragoudas E" first="E S" last="Gragoudas">E S Gragoudas</name>
<name sortKey="Kolodny, N H" sort="Kolodny, N H" uniqKey="Kolodny N" first="N H" last="Kolodny">N H Kolodny</name>
<name sortKey="Weinberg, D" sort="Weinberg, D" uniqKey="Weinberg D" first="D" last="Weinberg">D. Weinberg</name>
</noCountry>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Kohler, S J" sort="Kohler, S J" uniqKey="Kohler S" first="S J" last="Kohler">S J Kohler</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000777 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000777 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    ThuliumV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:1310341
   |texte=   In vivo sodium chemical shift imaging.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:1310341" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ThuliumV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu May 12 08:27:09 2016. Site generation: Thu Mar 7 22:33:44 2024